Effects of Ghrelin Administration on Dopamine and Effort

Clinical trial NCT05318924 · COMPLETED

Trial details

NCT number: NCT05318924
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2022-02-21
Primary completion: 2024-08-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.